Clinical Trial Update: Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing FiAsp and Aspart during postprandial exercise in adults with type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Aspart (insulin aspart)
• Fiasp (insulin aspart)

Snippet

Sponsor: Institut de Recherches Cliniques de Montreal | Conditions: Type 1 Diabetes Mellitus | Phase 4 | Status: COMPLETED